Forecasts data is unavailable for this security.
Consensus recommendation
- 16-Nov-23
- 15-Aug-24
- 19-Sep-24
- 17-Oct-24
- 07-Nov-24
Select bar for recommendation details.
Recommendations | 07-Nov-24 | |
---|---|---|
Buy | 1 | |
Outperform | 2 | |
Hold | 5 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in JPY
The 8 analysts offering 12 month price targets for JCR Pharmaceuticals Co Ltd have a median target of 665.00, with a high estimate of 2,000.00 and a low estimate of 600.00. The median estimate represents a 1.37% increase from the last price of 656.00.
High | 204.9% | 2,000.00 |
Med | 1.4% | 665.00 |
Low | -8.5% | 600.00 |
Dividends in JPY
Div growth (TTM) | 0.00% |
---|
More ▼
Earnings history & estimates in JPY
The next earnings announcement is expected on Jan 30, 2025.
Average growth rate | -42.09% |
Average growth rate | +59.58% |
More ▼
Revenue history & estimates in JPY
Average growth rate | -9.88% |
Average growth rate | +20.81% |
More ▼